Influence of Authorized Smokeless Tobacco Product Modified Risk Claims II: Laboratory Assessment of Sensory and Subjective Effects

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age21+
SponsorRoswell Park Cancer Institute

About this trial

This study seeks to measure the effects of smokeless tobacco product risk messages on sensory experiences and future intentions to use.

Eligibility criteria

Qualifiers

Age ≥ 21 years of age

Residing in 8 counties of Western NY (Erie, Niagara, Cattaraugus, Chautauqua, Allegheny, Livingston, Genesee, Orleans, Wyoming)

Smoke cigarettes every day, at least 5 cigarettes per day, for at least 1 year

Open to trying a non-combusted oral tobacco product

Disqualifiers

Age ≥ 21 years of age

Residing in 8 counties of Western NY (Erie, Niagara, Cattaraugus, Chautauqua, Allegheny, Livingston, Genesee, Orleans, Wyoming)

Smoke cigarettes every day, at least 5 cigarettes per day, for at least 1 year

Open to trying a non-combusted oral tobacco product

Trial design

Treatments tested in this trial

  • Copenhagen group
  • Snus group

Treatment groups

50 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Roswell Park Cancer Institute

Lead sponsor

National Cancer Institute (NCI)

Collaborator